For instance, E2F transcription factors have been observed to upregulate RRM2 in pancreatic cancer, while BRCA1 has been demonstrated to transcriptionally activate RRM2 in glioblastoma. This evidence concerns the gene BRCA1 and pancreatic neoplasm.